Rémi Gagnon

1.7k total citations
35 papers, 550 citations indexed

About

Rémi Gagnon is a scholar working on Physiology, Immunology and Allergy and Dermatology. According to data from OpenAlex, Rémi Gagnon has authored 35 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 17 papers in Immunology and Allergy and 7 papers in Dermatology. Recurrent topics in Rémi Gagnon's work include Asthma and respiratory diseases (16 papers), Allergic Rhinitis and Sensitization (15 papers) and Food Allergy and Anaphylaxis Research (9 papers). Rémi Gagnon is often cited by papers focused on Asthma and respiratory diseases (16 papers), Allergic Rhinitis and Sensitization (15 papers) and Food Allergy and Anaphylaxis Research (9 papers). Rémi Gagnon collaborates with scholars based in Canada, United States and France. Rémi Gagnon's co-authors include Gaston De Serres, Anne K. Ellis, Chantal Lemire, Stuart Carr, Anne Des Roches, Jacques Hébert, Yvan Boutin, Manale Ouakki, Ali Akoum and Jennifer Maloney and has published in prestigious journals such as Nature Medicine, Journal of Allergy and Clinical Immunology and Vaccine.

In The Last Decade

Rémi Gagnon

33 papers receiving 517 citations

Peers

Countries citing papers authored by Rémi Gagnon

Since Specialization

Citations

This map shows the geographic impact of Rémi Gagnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rémi Gagnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rémi Gagnon more than expected).

Fields of papers citing papers by Rémi Gagnon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rémi Gagnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rémi Gagnon. The network helps show where Rémi Gagnon may publish in the future.

Co-authorship network of co-authors of Rémi Gagnon

This figure shows the co-authorship network connecting the top 25 collaborators of Rémi Gagnon. A scholar is included among the top collaborators of Rémi Gagnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rémi Gagnon. Rémi Gagnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dupilumab Plus Medium‐Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High‐Dose ICS in Children With Uncontrolled Moderate‐to‐Severe Type 2 Asthma 2025 ·Pediatric Pulmonology ·Leonard B. Bacharier, Jorge Máspero, Nikolaos G. Papadopoulos, Rémi Gagnon, Theresa W. Guilbert, (unknown), (unknown), Mena Soliman	0
2	Lanadelumab’s impact on hereditary angioedema control and quality of life across disease activity subgroups 2025 ·Annals of Allergy Asthma & Immunology ·Andrea Zanichelli, Walter A. Wuillemin, Emel Aygören‐Pürsün, Aleena Banerji, Paula J. Busse, Stephen Betschel, Mauro Cancian, Rémi Gagnon, (unknown), Tamar Kinaciyan, Aharon Kessel, (unknown), Andreas Recke, H. James Wedner, (unknown), Maureen Watt, Irmgard Andresen, (unknown), (unknown), Inmaculada Martinez‐Saguer	0
3	Allergen immunotherapy 2024 ·Allergy Asthma and Clinical Immunology ·(unknown), Rémi Gagnon, (unknown), Anne K. Ellis	2
4	Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trial 2024 ·The Lancet Regional Health - Europe ·Antje Schuster, Davide Caimmi, Hendrik Nolte, Silviya Novakova, (unknown), (unknown), (unknown), Andrzej Emeryk, Rémi Gagnon, Oliver Pfaar	1
5	Simulation-based education to improve management of refractory anaphylaxis in an allergy clinic 2023 ·Allergy Asthma and Clinical Immunology ·Ana Maria Copaescu, François Graham, (unknown), Rémi Gagnon, Arnaud Robitaille, Mohamed Badawy, David Claveau, Anne Des Roches, Jean Paradis, Matthieu Robert de Saint Vincent, Philippe Bégin	3
6	Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis 2023 ·Allergy Asthma and Clinical Immunology ·Anne K. Ellis, Douglas P. Mack, Rémi Gagnon, (unknown), (unknown)	1
7	Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults 2023 ·The Journal of Allergy and Clinical Immunology In Practice ·(unknown), Émilie Proulx, (unknown), Aubert Lavoie, A. Gauthier, Rémi Gagnon, (unknown), (unknown), Louis Marois, (unknown), (unknown), Pierre-Michel Bédard, Manale Ouakki, Gaston De Serres, (unknown)	4
8	Bradykinin-induced angioedema in the emergency department 2022 ·International Journal of Emergency Medicine ·Jacques Hébert, (unknown), Hugo Chapdelaine, (unknown), (unknown), Rémi Gagnon, (unknown), (unknown), Matthieu Robert de Saint Vincent	10
9	Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada 2021 ·Allergy Asthma and Clinical Immunology ·Anne K. Ellis, Rémi Gagnon, (unknown), (unknown), (unknown)	3
10	Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial 2021 ·Nature Medicine ·Martin Metz, Gordon Sussman, Rémi Gagnon, Petra Staubach, Tonny Tanus, William H. Yang, Jeremy J. Lim, Holly J. Clarke, Joshua Galanter, Leslie W. Chinn, Tom Chu, Anastasia Teterina, Tracy Burgess, D. James Haddon, Timothy T. Lu, Marcus Maurer	94
11	Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis 2021 ·Allergy Asthma and Clinical Immunology ·Anne K. Ellis, Rémi Gagnon, David I. Bernstein, Hendrik Nolte	3
12	Reduction in Attacks in Hereditary Angioedema (HAE) With Berotralstat is Consistent Regardless of Prior Prophylactic Treatment: A Subgroup Analysis of the Phase 3 APeX-2 Trial 2021 ·Journal of Allergy and Clinical Immunology ·John Anderson, Rémi Gagnon, Jessica Best, Sharon C. Murray, Heather A. Iocca, Karl Sitz	1
13	Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report 2020 ·The Journal of Allergy and Clinical Immunology In Practice ·Moisés A. Calderón, Susan Waserman, David I. Bernstein, Pascal Demoly, John Aubrey Douglass, Rémi Gagnon, Constance H. Katelaris, Harold Kim, Harold S. Nelson, Yoshitaka Okamoto, Kimihiro Okubo, J. Christian Virchow, L. DuBuske, Thomas B. Casale, Giorgio Walter Canonica, Hendrik Nolte	14
14	Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs? 2019 ·Allergy Asthma and Clinical Immunology ·Anne K. Ellis, Rémi Gagnon, (unknown), (unknown)	11
15	Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated 2016 ·The Journal of Allergy and Clinical Immunology In Practice ·Jennifer Maloney, Gary Berman, Rémi Gagnon, David I. Bernstein, Harold S. Nelson, Jörg Kleine‐Tebbe, Amarjot Kaur, Qing Li, Hendrik Nolte	38
16	Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine 2010 ·Journal of Allergy and Clinical Immunology ·Rémi Gagnon, (unknown), Anne Des Roches, Chantal Lemire, Rhoda Kagan, Stuart Carr, Moussa Ouakki, (unknown), Gaston De Serres	57
17	Relative CD4 lymphopenia and a skewed memory phenotype are the main immunologic abnormalities in a child with Omenn syndrome due to homozygous RAG1-C2633T hypomorphic mutation 2009 ·Clinical Immunology ·Christine McCusker, (unknown), Françoise Le Deist, Aaron F. Hirschfeld, David Mitchell, Văn Hùng Nguyễn, Rémi Gagnon, Bruce Mazer, Stuart E. Turvey, Nada Jabado	6
18	Lol p I–specific IgE and IgG synthesis by peripheral blood mononuclear cells from atopic subjects in SCID mice 1995 ·Journal of Allergy and Clinical Immunology ·Rémi Gagnon, Yvan Boutin, (unknown)	11
19	Lol p I-induced IL-4 and IFN-γ production by peripheral blood mononuclear cells of atopic and nonatopic subjects during and out of the pollen season 1993 ·Journal of Allergy and Clinical Immunology ·Rémi Gagnon, Ali Akoum, Jacques Hébert	25
20	Seasonal enhancement of IL‐4 induced IgE synthesis by peripheral blood mononuclear cells of atopic patients 1993 ·Clinical & Experimental Allergy ·Rémi Gagnon, (unknown), Yvan Boutin, Jean‐Louis Hébert	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact